To address conflicting reports about the cardiovascular safety of DPP-4 inhibitors, researchers performed a large retrospective cohort study.
Stress Reduction Lowers Glucose Levels in Obese Women
Mindfulness: a potential intervention for T2DM?
Quiz: The 2017 AACE/ACE Lipid Management and CVD Prevention Guidelines
The 2017 lipid management guidelines have met both accolades and controversy. Take our quick quiz on the updates.
Beta Blockers Heighten Risk of CV Events in T2DM
Post-hoc analysis of ACCORD trial data suggests the indication of beta blocker therapy in T2DM patients be more closely examined.
Diabetes News Roundup: New Thoughts on Standard Thinking
Find research on diabetes patients that could shift your thinking on home blood glucose monitoring; metformin efficacy in T1DM; and race and A1c.
Processed Meats Top List of Foods Linked to CHD and Diabetes
How much of which foods truly promote cardiometabolic health? First-of-its-kind study quantifies impact of good food and bad.
Vitamin D Status & Cardiovascular Disease Risk
Three studies examined the relationship between CVD risk and vitamin D status in children, adolescents, and women.
Interesting T2DM: FDA News & Diabetes Risk
Our May list includes an app for titration of basal insulin, GI effects of GLP-1 agonists, and lifestyle intervention studies.
CV Events: Safety of Insulin
A study compared mortality and major adverse cardiovascular events in patients with type 2 diabetes prescribed metformin or insulin.
Dapagliflozin: All-Cause & Cardiovascular Mortality
Research has shown the beneficial effects of empagliflozin on all-cause and CV mortality. Does the same hold true for another SGLT2 inhibitor?
Statin Therapy with Type 2 Diabetes & Nephropathy
In patients with type 2 diabetes complicated by nephropathy, what is the real life effect of statin therapy on cardiovascular disease prevention?
CV Risks and Diabetes: Puerto Rican Population
Dr. Bobby Lazzara discusses a study looking at certain demographics and cardiovascular complications in a diabetic patient population in Puerto Rico.
Obesity Management: ENDO 2017 Highlights
Could corticosteroid use put your patients at a greater risk of metabolic syndrome?
By clicking Accept, you agree to become a member of the UBM Medica Community.